Oversigt over bivirkninger i fase II- undersøgelsen (BTC 9501) og i fase III- undersøgelsen vedrørende cervikal dystoni (MRZ 0013)
It should be noted that some adverse events have only been reported in patients who received Xeomin, such as dysphagia (reported in one patient in each of the Xeomin groups versus no patients in the Botox group).